ImClone Shares Rise on Pipeline Advance (AP)
Shares of ImClone Systems Inc. rose Thursday following the biotechnology company’s announcement it will move a head-and-neck cancer drug candidate into midstage clinical trials.
Shares of ImClone Systems Inc. rose Thursday following the biotechnology company’s announcement it will move a head-and-neck cancer drug candidate into midstage clinical trials.
Similar/Related/News: